• Family of patient who died after orthopedic surgery wins $35M verdict against hospital
  • Orthopedic surgeon wins $20M verdict against Johnson & Johnson
  • Minnesota orthopedic group hit with $111M negligence verdict
  • Orthopedic patient's death highlights potential dangers of prior authorization
  • Spine surgeon's video hits 1 million views on TikTok
  • Spine surgeon killed in Oklahoma hospital shooting
  • Spine surgeon owes $17M to paralyzed patient
  • Providence to pay $22.7M to settle unnecessary spine surgery allegations
  • Spine surgeon gets jail time for abusing patient during hospital visit
  • 'They're on really thin ice': Why 1 insurer has drawn spine surgeons' ire
  • Connecticut hospital to appeal $12.5M verdict to family of patient who died after orthopedic surgery
  • Orthopedic surgeon must face suit in patient's death
  • Spine surgeon 1 of 9 physician billionaires on Forbes' 2022 list
  • 23 spine device companies to watch in 2022
  • 4 spine technologies that promised more than they delivered
  • Orthopedic surgeon salary vs. average household income in each state
  • Orthopedic surgeon's health system exit steeped in controversy
  • Terminated orthopedic surgeon contracts with another New York hospital
  • Orthopedic surgeon convicted of battery at hospital
  • Billionaire spine surgeon buys $23.9M mansion
  • UArizona neurosurgery chair dies after motorcycle collision
  • The spine tech surgeons say will explode in the next 5 years
  • Texas spine surgeon sued by State Farm over 'unnecessary' procedures
  • Could Medtronic's spine business be the next medtech spinoff?
  • Ex-NFL player gets 5 years in prison for $2.9M healthcare fraud scheme
  • 41 'rising stars' in orthopedics
  • Orthopedic surgeon indicted in $10M telemedicine fraud scheme
  • Neurosurgeon's startup hits $1.2B valuation
  • Orthopedic surgeon fined for operating on wrong knee
  • Good news, bad news for orthopedic surgeons: 6 observations
  • Lawsuits build against Aetna's spine surgery coverage
  • Former spine surgeon owes $13M to 2 women over unnecessary procedures
  • Walmart's latest partnership pushes retailer into spine care
  • Texas spine surgeon's $11M verdict being appealed
  • 10 power players in orthopedics
  • Rothman Orthopaedics to become national brand, but no 'aspirations to go beyond US'
  • Sports medicine physician fired amid misconduct allegations involving patients
  • Orthopedic surgeon allegedly exaggerated patient visits to defraud insurers
  • Top orthopedic hospital in every state: US News
  • Orthopedic surgeon asking for misconduct charges to be dropped
  • Zimmer-Biomet $14B merger finally complete — 6 things to know

    Zimmer-Biomet $14B merger finally complete — 6 things to know

    Laura Dyrda -  

    The U.S. Federal Trade Commission granted clearance for Zimmer's acquisition of Biomet today.

    Here are six things to know:

     

    1. More than a year after announcing plans to merge, the Zimmer-Biomet combination is complete today. Zimmer also sold the Zimmer Unicompartmental High Flex Knee system to Smith & Nephew; the sale was announced today and set for completion within the next three days.

     

    2. Zimmer acquired Biomet for $14 billion in a cash and equity transaction. The combined companies' corporate name will be Zimmer Biomet Holdings and the company will begin trading on the New York Stock Exchange and SIX Swiss Exchange under the ZBH ticker symbol beginning June 29.

     

    3. After the combination, Zimmer Biomet is the leading innovator in the $45 billion musculoskeletal healthcare market. Zimmer Biomet's scale will increase competitiveness in core franchises and strengthen its presence in emerging markets.

     

    4. Zimmer Biomet expects to reach net annual synergies of around $350 million by the third year after the combination; $135 million is expected in the first 12 months. The transaction is expected to be double-digit accretive to the Company's adjusted earnings per share in the first year.

     

    5. Excluding Biomet acquired revenue, the second quarter constant currency revenue growth is expected to reach 1 percent to 1.5 percent. The full year 2015 revenue is expected to increase 1.5 percent to 2 percent compared to pro forma 2014 revenues. The company will provide additional financial information on the transaction and expectations for the balance of fiscal 2015 in the second quarter earnings conference call on July 30.

     

    6. Zimmer Biomet's board is now 12 members, with Michael W. Michelson and Jeffrey K. Rhodes appointed to the board. Both were members of the Biomet board of directors.

     

    "The coming together of Zimmer and Biomet is a momentous achievement," said Zimmer Biomet President and CEO David Dvorak. "We are excited to move forward as one company and to pursue new opportunities that benefit patients, healthcare professionals and employees around the globe."

     

    Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

    Featured Learning Opportunities

    Featured Webinars

    Featured Podcast

    Featured Whitepapers